Gordon Saxty
44Patents
12h-index
89Co-inventors
80Inventor score
Filing activity: Dec 23, 2004 → Dec 21, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9447098B2 | Pteridines as FGFR inhibitors | Chemistry; Metallurgy | 26 | Active |
| US9290478B2 | Substituted quinoxalines as FGFR kinase inhibitors | Chemistry; Metallurgy | 26 | Active |
| US9303029B2 | Substituted quinoxalines as FGFR kinase inhibitors | Chemistry; Metallurgy | 26 | Active |
| US9309242B2 | Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors | Chemistry; Metallurgy | 26 | Active |
| US8895745B2 | Bicyclic heterocyclic compounds as FGFR inhibitors | Chemistry; Metallurgy | 24 | Active |
| US9439896B2 | Quinolines as FGFR kinase modulators | Chemistry; Metallurgy | 23 | Active |
| US9464071B2 | Pyrazolyl quinoxaline kinase inhibitors | Chemistry; Metallurgy | 23 | Active |
| US8895601B2 | Pyrazolyl quinoxaline kinase inhibitors | Chemistry; Metallurgy | 23 | Active |
| US9856236B2 | Substituted quinoxalines as FGFR kinase inhibitors | Chemistry; Metallurgy | 17 | Active |
| US9850228B2 | Pyrazolyl quinoxaline kinase inhibitors | Chemistry; Metallurgy | 17 | Active |
| US8071614B2 | Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors | Human Necessities | 14 | Active |
| US8131527B1 | FGFR pharmacophore compounds | Physics | 14 | Active |
| US10039759B2 | Quinolines as FGFR kinase modulators | Chemistry; Metallurgy | 11 | Active |
| US10045982B2 | Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors | Chemistry; Metallurgy | 11 | Active |
| US10052320B2 | Substituted quinoxalines as FGFR kinase inhibitors | Chemistry; Metallurgy | 11 | Active |
| US9617283B2 | Bicyclic heterocycle compounds and their uses in therapy | Chemistry; Metallurgy | 10 | Active |
| US9617248B2 | Bicyclic heterocycle compounds and their uses in therapy | Chemistry; Metallurgy | 10 | Active |
| US9663512B2 | Bicyclic heterocycle compounds and their uses in therapy | Chemistry; Metallurgy | 8 | Active |
| US8481531B2 | Bicyclic heterocyclyl derivatives as FGFR kinase inhibitors for therapeutic use | Human Necessities | 8 | Active |
| US8859582B2 | Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors | Human Necessities | 7 | Active |
| US8076354B2 | Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors | Chemistry; Metallurgy | 7 | Active |
| US9783538B2 | Bicyclic heterocycle compounds and their uses in therapy | Human Necessities | 7 | Active |
| US8513276B2 | Imidazo[1,2-a]pyridine compounds for use in treating cancer | Chemistry; Metallurgy | 6 | Active |
| US10519137B2 | Pyrazolyl quinoxaline kinase inhibitors | Chemistry; Metallurgy | 5 | Active |
| US10272087B2 | Pteridines as FGFR inhibitors | Chemistry; Metallurgy | 5 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.